Search Results
FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More
FDA Approvals in Bladder Cancer and Hodgkin Lymphoma, Breakthrough Designation in AML, and More
FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC
FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More
Breakthrough Designation in ALL, HIFU FDA Approval, Breast Cancer Screening Update, and More
FDA Approvals in Breast Cancer and Bladder Cancer and Phase III Data With Larotrectinib
Review on 2016 FDA Approvals, Halt on AML Trials, and More
FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More
Breakthrough Designation in AML, Trials Halted in Head and Neck Cancer, and More
Breast Cancer Breakthrough - Prevention and Treatment
Study Could Provide Breast Cancer Breakthrough
ODAC Support for 5 Agents, NDA in Melanoma, Breakthrough Designation in GVHD, and More